Business Description
![NexImmune Inc NexImmune Inc logo](https://static.gurufocus.com/logos/0C0000C1W3.png?14)
NexImmune Inc
NAICS : 541713
SIC : 2834
ISIN : US65344D2080
Share Class Description:
NEXI: Ordinary SharesDescription
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 64.54 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5.1 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 4.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.59 | |||||
9-Day RSI | 27.02 | |||||
14-Day RSI | 31.52 | |||||
6-1 Month Momentum % | 28.84 | |||||
12-1 Month Momentum % | -56.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 0.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.5 | |||||
Shareholder Yield % | -71.48 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -233.74 | |||||
ROA % | -149.83 | |||||
ROIC % | -564.8 | |||||
ROC (Joel Greenblatt) % | -758.48 | |||||
ROCE % | -220 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.15 | |||||
Price-to-Tangible-Book | 1.15 | |||||
EV-to-EBIT | 0.04 | |||||
EV-to-EBITDA | 0.04 | |||||
EV-to-FCF | 0.05 | |||||
Price-to-Net-Current-Asset-Value | 248 | |||||
Earnings Yield (Greenblatt) % | 2500 | |||||
FCF Yield % | -634.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NEXI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NexImmune Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -24.1 | ||
Beta | 2.18 | ||
Volatility % | 599.28 | ||
14-Day RSI | 31.52 | ||
14-Day ATR ($) | 0.201774 | ||
20-Day SMA ($) | 2.85294 | ||
12-1 Month Momentum % | -56.56 | ||
52-Week Range ($) | 1.2501 - 28.6949 | ||
Shares Outstanding (Mil) | 1.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NexImmune Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NexImmune Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
NexImmune Inc Frequently Asked Questions
What is NexImmune Inc(NEXI)'s stock price today?
The current price of NEXI is $2.48. The 52 week high of NEXI is $28.69 and 52 week low is $1.25.
When is next earnings date of NexImmune Inc(NEXI)?
The next earnings date of NexImmune Inc(NEXI) is 2024-08-15 Est..
Does NexImmune Inc(NEXI) pay dividends? If so, how much?
NexImmune Inc(NEXI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |